Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Yudong Wang and George Lau.
Yudong Wang
Connection Strength
1.393
George Lau
  1. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19. Metabolism. 2021 02; 115:154437.
    View in: PubMed
    Score: 0.229
  2. Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020 Sep; 14(5):701-710.
    View in: PubMed
    Score: 0.224
  3. Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'. J Hepatol. 2020 09; 73(3):718-719.
    View in: PubMed
    Score: 0.220
  4. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation. Hepatol Int. 2020 Jul; 14(4):432-436.
    View in: PubMed
    Score: 0.219
  5. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020 08; 73(2):451-453.
    View in: PubMed
    Score: 0.219
  6. Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis. Hepatology. 2017 07; 66(1):13-26.
    View in: PubMed
    Score: 0.180
  7. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020 09 12; 71(6):1393-1399.
    View in: PubMed
    Score: 0.056
  8. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases. Sci Rep. 2017 11 28; 7(1):16482.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.